Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma

BACKGROUND: Gastroesophageal adenocarcinoma (GOA) has poor clinical outcomes and lacks reliable blood markers. Here we present circulating tumour DNA (ctDNA) as an emerging biomarker. METHODS: Forty patients (17 palliative and 23 curative) were followed by serial plasma monitoring. Primary tumour DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Openshaw, Mark R., Suwaidan, Ali Abdulnabi, Ottolini, Barbara, Fernandez-Garcia, Daniel, Richards, Cathy J., Page, Karen, Guttery, David S., Thomas, Anne L., Shaw, Jacqui A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555811/
https://www.ncbi.nlm.nih.gov/pubmed/32719550
http://dx.doi.org/10.1038/s41416-020-1002-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555811/
https://www.ncbi.nlm.nih.gov/pubmed/32719550
http://dx.doi.org/10.1038/s41416-020-1002-8

Ejemplares similares